InvestSMART

Invion Limited (ASX: IVX) - Announcements

- Current share price for IVX : $0.038

ASX company news and announcements for Invion Limited (IVX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invion Limited (IVX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invion Limited (IVX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invion Limited (IVX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Extension of SPP closing date to 7 December 2015 27 Nov 2015 3:23PM $0.008 $0.038 risen by 375%
$4 Investor newsletter 25 Nov 2015 11:18AM $0.008 $0.038 risen by 375%
$4 Results of Annual General Meeting 18 Nov 2015 5:17PM $0.009 $0.038 risen by 322.22%
$4 Chairman's Address and CEO presentaiton to AGM 18 Nov 2015 2:41PM $0.009 $0.038 risen by 322.22%
$4 Smoking cessation trial results of ongoing data analysis 17 Nov 2015 9:55AM $0.008 $0.038 risen by 375%
$4 Share Purchase Plan Cleansing Notice 10 Nov 2015 9:17AM $0.012 $0.038 risen by 216.67%
$4 Letter to shareholders SPP rules and sample application 10 Nov 2015 9:17AM $0.012 $0.038 risen by 216.67%
$4 Invion announces Share Purchase Plan 10 Nov 2015 9:16AM $0.012 $0.038 risen by 216.67%
$4 Corporate presentation November 2015 10 Nov 2015 9:04AM $0.012 $0.038 risen by 216.67%
$4 Litigation update - decision of High Court 4 Nov 2015 2:10PM $0.011 $0.038 risen by 245.45%
$4 Completion of enrolment in INV102 phase II asthma study 2 Nov 2015 1:05PM $0.011 $0.038 risen by 245.45%
$4 Appendix 4G - key to corporate governance disclosures 30 Oct 2015 11:04AM $0.011 $0.038 risen by 245.45%
$4 Corporate Governance Statement 30 Oct 2015 11:02AM $0.011 $0.038 risen by 245.45%
$4 Appendix 4C - quarterly 30 Oct 2015 10:24AM $0.011 $0.038 risen by 245.45%
$4 AGM Notice of Meeting and sample proxy form 16 Oct 2015 1:38PM $0.012 $0.038 risen by 216.67%
$4 Receipt of R&D tax rebate and repayment of Metamor loan 9 Oct 2015 10:22AM $0.016 $0.038 risen by 137.50%
$4 Dr Glass discusses P2 smoking cessation trial results 6 Oct 2015 2:38PM $0.015 $0.038 risen by 153.33%
$4 Invion - successful completion of P2 study of INV102 5 Oct 2015 9:08AM $0.013 $0.038 risen by 192.31%
$4 Corporate Presentation - September 2015 7 Sep 2015 10:02AM $0.015 $0.038 risen by 153.33%
$4 Invion announces no secondary capital raise 7 Sep 2015 10:01AM $0.015 $0.038 risen by 153.33%
$4 Notice under s708A Corporations Act - cleasning notice 3 Sep 2015 10:49AM $0.014 $0.038 risen by 171.43%
$4 Placement - information required under LR3.10.5A 3 Sep 2015 10:47AM $0.014 $0.038 risen by 171.43%
$4 Appendix 3B - issue of placement shares and options 3 Sep 2015 10:45AM $0.014 $0.038 risen by 171.43%
$4 Notice under section 708A Corporations Act 1 Sep 2015 10:03AM $0.018 $0.038 risen by 111.11%
$4 Invion completes placement to institutional US investor 1 Sep 2015 10:02AM $0.018 $0.038 risen by 111.11%

601 - 625 of 717 results

Page 25 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.